Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

UTXFqOG7pCHhuqNY4bq/4bq/w5TDmeG6u+G7gDbhu4HhuqM8w5lSxII0WOG7pMOqWOG7pMOjQOG7geG7pOG7gTXhu4fhuqch4bukKTYg4buH4buk4buBw6o54bukdeG6rkrhu7PDui3FqFfhu6QpP+G7h+G7pOG7gTZdxIPhu6QpaWUh4bukISbhurvhu6Thurs1PuG6u1EvNcWoUlHhurvhu6Qh4bqjWOG6v+G6v8OUw5nhurvDvTxYKMOZUsSCNMOdbeG7pMWoxagv4bus4buc4bukxII0WOG7pCnhu7bhu6QhNeG6r+G7pMOqWOG7pMOjQOG7geG7pOG6o+G6r+G7sjbhu6Thu4E14buH4bqnIeG7pCk2IOG7h+G7pOG7gcOqOeG7pC4wxIM14bukajZdw6Phu6QpacSRxIM04bukNeG6peG7pDUm4bq74bukISbhurvhu6R14bquSuG7s8O6LcWoV+G7pCk/4buH4buk4buBNl3Eg+G7pClpZSHhu6QhJuG6u+G7pOG6uzU+4bq74bukamQ24buk4buBXcSD4bukNOG6szbhu6Thu49qNjNYajbDquG7nOG7pOG7gcOq4bqvxIM04bukLuG6pzbhu6Qh4bu0xIM14buk4bq/4bqn4bukIVjhu6TDo0Ah4bukLjDEgzXhu6TDqeG7pMSDaWQh4bukxIPDnW3hu6Qp4bu24bukamll4buB4buk4bq94buHWeG7pMOj4bqnIeG7pOG7sOG7puG7puG7ouG7puG7puG7puG7pMSDNGnEkTbhu6JRL+G6u1JR4bq74bukIeG6o1jhur/hur/DlMOZ4bq7dOG6ryhtw5lSUTbDozThu6Qh4bqjWOG6v+G6v8OUw5khw6Phur8t4bq7NeG6r+G7geG6r8OZ4buk4buBNuG7geG6ozzDlMOZxII0WOG7pMOqWOG7pMOjQOG7geG7pOG7gTXhu4fhuqch4bukKTYg4buH4buk4buBw6o54bukdeG6rkrhu7PDui3FqFfhu6QpP+G7h+G7pOG7gTZdxIPhu6QpaWUh4bukISbhurvhu6Thurs1PuG6u+G7pDU4xIM14buk4bu0xIM14bukxajDmeG7pOG6v8OqIcOUw5kvLyHhu6IuWOG6r+G7gTVYxIM1NeG6r1jhu6JqxIMvNsOjNC8oPOG6v+G6oeG7geG6r+G6uy/Egzxr4bq/L8av4bumxq/hu6gvxajhu67hu64o4buw4bum4buu4buw4buw4buw4buq4buB4buu4buwxq/hu67huqPFqOG7oms8LuG6u8OZ4bukWOG6o+G7gcOUw5nEgjRY4bukw6pY4bukw6NA4buB4buk4buBNeG7h+G6pyHhu6QpNiDhu4fhu6Thu4HDqjnhu6R14bquSuG7s8O6LcWoV+G7pCk/4buH4buk4buBNl3Eg+G7pClpZSHhu6QhJuG6u+G7pOG6uzU+4bq7w5nhu6QoWOG7gVgt4bq7NeG6r+G7geG6ry3huq/DqjY0NsSDWOG6oy3hur/DqiHDlMOZNeG7geG7geG6u+G6v8agLy8hKMSDNsOjNOG7omo2POG7gcSDWMOj4bq74bqj4buH4bq/4buiasSDL+G7geG7rMav4bumL+G7h+G6u+G6o+G6r1goPCgvLuG6r8Og4bqv4bqhWC/Gr+G7psav4bumX+G7puG7rF/FqMWoL1hqNjNYajbDquG7osOg4bq7NMOZ4bukL1Lhu49qNjNYajbDquG7pCnhu7bhu6QpaWUh4bukITXhu4dtMcSD4bukKSLEg+G7pCFZIeG7pC4wxIM14bukajYwxIPhu6Rqw53hu6Thurs14bq3xIM04buk4bqhNVnDo+G7pOG7geG7sjbhu6TEgjRY4bui4buk4bug4buTxIM1xqDhu6R04bqj4bqv4bqvw6MuPMOqNFBRL+G6u1JR4bq74bukIeG6o1jhur/hur/DlMOZ4bq7dOG6ryhtw5lS4buAw6rhuq/EgzThu6TDo+G6qeG7geG7pOG7gTXhuqXEgzThu6QhWeG6r+G7pC5Z4bqv4bukITU34buc4buk4bq84buH4buN4bukw7k/4buH4buk4buBaeG7pOG7gcOq4buLIeG7pOG7gTYi4bq74bukxII0WOG7pOG7oMOKw7rhu7N4UOG7pCE14bqv4bukLjYi4buB4buk4bqj4bql4buk4buBNeG7h+G6pyHhu6Thu49qNjNYajbDquG7pCk/4buH4buk4buBNl3Eg+G7pCnhu7bhu6QpaWUh4bukIeG7h8SDNOG7pCEm4bq74bukITXhuq/hu6QhWSHhu6QuMMSDNeG7pGo2MMSD4bukasOd4buk4bq7NeG6t8SDNOG7pOG6oTVZw6Phu6Thu4HDql3Eg+G7pOG7geG6r8OdxIPhu6Thur3hu4fhuqch4bui4bukw4rDuuG7s3jhu6ThuqPDneG7pCljxIPhu6RqOeG7pCHhu4fEgzThu6QhJuG6u+G7pOG6oTbEgzXhu6Thurs1N+G7pCE14bqv4bukNeG6r+G7suG7geG7pCnhuqnEgzThu6Thu4E14buJ4bukxIM0NTYww6Phu6Thu4E14buH4bqnIeG7pGrDneG7pCHhurHhu6Thu7Dhu6bhu5Lhu6Qh4bqr4buk4bq7NT/Eg+G7pOG7gcOq4bqvxIM04buk4buBOuG6u+G7pCnhuq/DncSD4bukdTU8w6PDiljDquG7pC3hu6TEgzXDneG7pOG6v+G7tMSD4bukbOG7hybhu4Hhu6Thu4E14buH4bqnIeG7pOG7j2o2M1hqNsOq4buiUS/hurtSUeG6u+G7pCHhuqNY4bq/4bq/w5TDmeG6u3Thuq8obcOZUnThuqnhu6RN4buk4buBIuG7pMSCNFjhu6Qp4bu24bukISbhurvhu6Thurs1PuG6u+G7pCE14bqv4buk4buBNeG7h+G6pyHhu6Thu49qNjNYajbDquG7pOG7gTU84bqv4bukw6Phuqnhu4Hhu6Thur3hu4dZ4buk4buBw6o4xIM14buk4bq7NV3hu6QhNeG7hzvEg+G7pCk9IeG7pC42MOG7geG7pClpZSHhu6Thu4E14buLIeG7pDU2MMSD4buk4buBw6rhuq/EgzThu6Thu4E1xJE24bukNDZYxIPhu6TEgzRAxIPhu6Lhu6R1WSHhu6Q14bqv4buy4buB4bukKeG6qcSDNOG7pOG7gTXhu4nhu6TEgzQ1NjDDo+G7pOG7geG7sjbhu6TEgjRY4bukKDYyxIPhu6TDqljhu6TEgzVYxIM14bukasOd4bukIeG6seG7pOG6veG7h23hu6TDo+G6peG7pMSDNeG6teG7pDVjxIPhu6Thur/huq/hu6RqZDbhu6TEgzU2IOG7h+G7pOG6veG7h+G6pyHhu6Q0Nljhu6ThuqE1WSHhu5zhu6Thu4HDquG6r8SDNOG7pC7huqc24bukIeG7tMSDNeG7pCg5ITXhu6QuMMSDNeG7pClYxIM04buk4bqjKm3hu6ThuqNYxIPhu6RqZDbhu6Thu4Hhuqch4bukKeG6qeG7pMSDNVjEgzXhu6JRL+G6u1JR4bq74bukIeG6o1jhur/hur/DlMOZ4bq7dOG6ryhtw5lSw73huq024buk4buB4buHP8SD4buk4buBw6ppZCHhu5zhu6TEgzRpxJE24bukKcOtxIM04bukKT/hu4fhu6TDisO64buzeOG7pOG6oDbDqjbhuqPhuqPhu6TDusOjNuG7gcOqNjxq4bukITXhuq/hu6QuNiLhu4Hhu5zhu6R1NTzDo8OKWMOq4bukIeG6seG7pOG6oSLhu6Q14bqv4buyITXhu6Thur/hu7TEg+G7pGzhu4cm4buB4bukKWfhu6Thu4E14buH4bqnIeG7pCkx4bukKTYg4buH4buk4buBw6o54bukITXhuq/hu6ThuqE14bqv4bu0xIM04buk4bus4bum4bui4bum4bum4bum4bukxIM0acSRNuG7pMOjYjbhu6Thu4E1WcSDNOG7ouG7pOG7gDU84bqv4buk4bqlxIM04bukw7rDozbhu4HDqjY8auG7nOG7pCHhurHhu6Q1Y8SD4bukxajhu6bhu6Thur3hu4fhuqch4bukNDZY4bukKeG7tuG7pCkg4bukxIM0NTnhu6TDo+G7h1jhu6Thu4E14buH4bqnIeG7pOG7j2o2M1hqNsOq4bukIWdY4bukxII0WOG7olEv4bq7UlHhurvhu6Qh4bqjWOG6v+G6v8OUw5nhurt04bqvKG3DmVJKZDbhu6Q1Y8SD4buk4buw4bum4bum4bui4bum4bum4bum4buk4buBw6ppxJHEgzThu6Q1ZeG6u+G7nOG7pMSCNFjhu6QpWMSDNOG7pGwi4bq74buk4buBNcOt4buk4buo4buk4buBw6pdxIPhu6Thu4E1IuG7pDQ2ZDbhu6RqIOG7pOG6v+G6p+G7pCFY4bukw6NAIeG7pC4wxIM14bukdeG6rkrhu7PDui3FqFfhu6Lhu6Thu4Dhu4dt4bukxIM1Nl3Eg+G7nOG7pMSDaWQh4bukxIPDnW3hu6TDo2Q24bukITVh4bukNDU24bukxIM1OsSD4bukNWPEg+G7pOG7rOG7ouG7sOG7puG7puG7pCFY4buk4buB4buJ4bukauG6r8SDNOG7nOG7pMOj4bqp4buB4buk4buBw7Lhu6ThuqMw4buk4buBaWPEgzThu6Qp4bqnNuG7pOG7gTUm4bq74buk4bq/4bqv4bukamQ24bukxIM1NiDhu4fhu6Thur3hu4fhuqch4bukNDZY4buk4bqhNVkh4bui4bukw702MMSD4bukxIM1NiDhu4fhu6QpOVjhu6Thurs1aWPEgzThu5zhu6Thu4HDquG6r8SDNOG7pCnhurHhu6Qh4bqx4buk4buBNWfhu6Qp4bql4bukw4Phuq/hur/huqFqWOG7nOG7pCnhu7bhu6QuQOG7geG7pCk/4buH4bukKOG6ueG7pC7hurXhu6QhWSHhu6QuNjDEg+G7pOG6uzVZ4bq74buk4bq7NeG6r8SDNOG7pOG7geG6tVjhu6QpaWUh4bukWeG6u+G7pCk94buB4bukKTHhu6ThuqE14bqnxIM04bukITUi4bukKDkhNeG7pC4wxIM14buiL+G7olEv4bq7UlHhurvhu6Qh4bqjWOG6v+G6v8OUw5nhurvhu4/hu4fhu4E14bqvw6rDmVLhu6BKNjzhu4HEg1jDoytQUS/hurtS